Abstract
Objective
To describe musculocutaneous MR-findings responsible for disability in chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic cell transplantation (HCT).
Material and methods
Between June 2005 and February 2008, we performed whole-body musculoskeletal magnetic resonance imaging (MRI; n = 12) or regional MRI (n = 4) in 16 consecutive patients presenting with disabling sclerodermatous cGVHD (e.g., skin edema, fixed deep dermal sclerosis, joint contractures, painful muscular contractures, or myalgia).
Results
In all patients, MRI showed musculocutaneous abnormalities reflecting different degrees of inflammation and collagen tissue involvement of the skin (n = 10), subcutaneous fat tissue (n = 13), muscle fasciae (n = 16), subfascial muscular septae (n = 6), or findings compatible with myositis (n = 3). The most frequently involved muscle fasciae comprised those of the vastus lateralis muscle (n = 12), biceps femoris muscle (n = 11), gastrocnemius medialis muscle (n = 8), serratus anterior muscle, and latissimus dorsi muscle (each, n = 5). Increased signal of involved tissues on STIR-images and fat-saturated postgadolinium T1-weighted images represented the most frequent MR-signal abnormalities.
Conclusion
MR imaging of musculocutaneous cGVHD allows accurate evaluation including assessment of deep tissue infiltration and assists in the differential diagnosis.
Similar content being viewed by others
References
Graze PR, Gale RP. Chronic graft versus host disease: a syndrome of disordered immunity. Am J Med 1979; 66: 611–620.
Deeg HS, Storb R, Thomas ED. Bone marrow transplantation: a review of delayed complications. Br J Haematol 1984; 57: 185–208.
Penas PF, Jones-Cabllero M, Aragues M, et al. Sclerodermatous graft-vs-host disease. Clinical and pathological study of 17 patients. Arch Dermatol 2002; 138: 924–934.
Shulman HM, Sale GE, Lerner KG, et al. Chronic cutaneous graft-versus-host disease in man. Am J Pathol 1978; 92: 545–570.
Janin-Mercier A, Saurat JH, Bourges M, et al. The lichen planus-like and sclerotic phases of the graft versus host disease in man: an ultrastructural study of six cases. Acta Derm Venereol (Stockh) 1981; 61: 187–193.
Janin A, Socie G, Devergie A, et al. Fasciitis in chronic graft-versus-host disease: a clinicopathologic study of 14 cases. Ann Intern Med 1994; 120(12): 993–998.
Anderson BA, Young PV, Kean WF, et al. Polymyositis in chronic graft-versus-host disease. A case report. Arch Neurol 1982; 39: 188–190.
Pier N, Dubowitz V. Chronic graft versus host disease presenting with polymyositis. Br Med J (Clin Res Ed) 1983; 286: 2024.
Pavletic SZ, Martin P, Lee SJ, et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant 2006; 12(3): 252–266, Mar.
Aractingi S, Chosidow O. Cutaneous graft-versus-host disease. Arch Dermatol 1998; 134: 602–612.
Vazquez Botet MV, Sanchez JL. The fascia in systemic scleroderma. J Am Acad Dermatol 1980; 2: 36–42.
Krieg T, Meurer M. Systemic scleroderma. Clinical and pathophysiologic aspects. J Am Acad Dermatol 1988; 18: 457–481.
Sato N, Okamoto S, Mori T, et al. Recurrent acute myositis after allogeneic bone marrow transplantation for myelodysplasia. Hematology 2002; 7(2): 109–112.
Biju G, Debashis D, Mammen C, et al. Polymyositis—an unusual manifestation of chronic GVHD. Rheumatol Int 2001; 20: 169–170.
Parker P, Chao NJ, Be-Ezra J, et al. Polymyositis as a manifestation of chronic graft versus host disease. Medicine (Baltimore) 1996; 75(5): 279–285.
Parker P, Chao NJ, Be-Ezra J, et al. Polymyositis as a manifestation of chronic graft versus host disease. Medicine (Baltimore) 1996; 75(5): 279–285.
Pincus SH, Ramesh KS, Wyler DJ. Eosinophils stimulate fibroblast DNA synthesis. Blood 1987; 70: 572–574.
Ustun C, Ho G Jr. Eosinophilic fasciitis after allogeneic stem cell transplantation: a case and review of the literature. Leuk Lymphoma 2004; 45(8): 1707–1709.
Caperton EM, Hataway DE, Dehner LP. Morphea, fasciitis and scleroderma with eosinophilia. A broad spectrum of disease. Arthritis Rheum 1976; 19: 792–793.
Markusse HM, Dijkmans BA, Fibbe WE. Eosinophilic fasciitis after allogeneic bone marrow transplantation. J Rheumatol 1990; 17: 692–694.
Janin A, Torpier G, Courtin P, et al. Segregation of eosinophil proteins in alveolar macrophage compartments in chronic eosinophilic pneumonia. Thorax 1993; 48: 57–62.
Desruelles F, Lacour J-P, Chevallier P, et al. Radiation myo-fasciitis. Acta Derm Venerol 2000; 80: 310–311.
McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF-receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999; 97: 133–140.
Broome DR, Girguis MS, Baron PW, et al. Gadodiamide-associated nephrogenis systemic fibrosis: why radiologists should be concerned. AJR 2007; 188: 586–592.
Phelps RG, Fleischmajer R. Clinical, pathologic, and immunopathologic manifestations of the toxic oil syndrome. Analysis of fourteen cases. J Am Acad Dermatol 1988; 18: 313–324.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Horger, M., Boss, A., Bethge, W. et al. MR findings in patients with disabling musculocutaneous chronic graft-versus-host disease. Skeletal Radiol 37, 885–894 (2008). https://doi.org/10.1007/s00256-008-0535-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-008-0535-3